Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2005
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
Owen A O'Connor, Mark L Heaney, Lawrence Schwartz, et al.
Psychological Assessment
|
October 1, 2004
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples
Katherine N DuHamel, Jamie Ostrof, Teresa Ashman, et al.
British Journal of Haematology
|
February 18, 2009
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial
Owen A O'Connor, Craig Moskowitz, Carol Portlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes
Owen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
JACC. Clinical Electrophysiology
|
October 31, 2025
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: The ULTRA-HFIB Pilot
William Whang, Devi Nair, Rahul Bhardwaj, et al.
Haematologica
|
July 22, 2021
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
Richard J Lin, Colette N Owens, Esther Drill, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Neuro-Oncology
|
May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
Alissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
The New England Journal of Medicine
|
October 16, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2005
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
Owen A O'Connor, Mark L Heaney, Lawrence Schwartz, et al.
Psychological Assessment
|
October 1, 2004
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples
Katherine N DuHamel, Jamie Ostrof, Teresa Ashman, et al.
British Journal of Haematology
|
February 18, 2009
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial
Owen A O'Connor, Craig Moskowitz, Carol Portlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes
Owen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
JACC. Clinical Electrophysiology
|
October 31, 2025
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: The ULTRA-HFIB Pilot
William Whang, Devi Nair, Rahul Bhardwaj, et al.
Haematologica
|
July 22, 2021
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
Richard J Lin, Colette N Owens, Esther Drill, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
Mrinal Gounder, Ved Desai, Deborah Kuk, et al.
Neuro-Oncology
|
May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
Alissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
The New England Journal of Medicine
|
October 16, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, et al.
Page
of 4